MAZE · Maze Therapeutics, Inc.
Market Cap
$1.46B
Shares
55.55M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1842295
CUSIP
578784100
13F (30d)
124 filings
124 filers
Visit website
Investor relations